Top Markets
Coin of the day
Galera Therapeutics, Inc. Galera Therapeutics, Inc.

Galera Therapeutics, Inc.

GRTX
Rang în acțiuni #33966
Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation and commercialization of therapies aimed at revolutionizing cancer radiotherapy. Its lead investigational drug, avasopasem manganese (GC4419), functions as a small molecule superoxide dismutase mimetic. This compound has successfully completed a Phase III clinical trial targeting severe oral mucositis induced by radiation therapy in head and neck cancer (HNC) patients. Furthermore, GC4419 is currently undergoing Phase IIa clinical trials for radiotherapy-induced esophagitis in lung cancer patients, as well as for HNC patients undergoing standard-of-care radiation treatment. The company is also progressing with GC4711, another superoxide dismutase mimetic candidate, which is in a Phase I/II clinical trial. This trial evaluates its combination with stereotactic body radiation therapy (SBRT) for individuals diagnosed with non-small cell lung cancer and locally advanced pancreatic cancer. Galera Therapeutics was founded in 2012 and maintains its headquarters in Malvern, Pennsylvania.
Preț acțiune
$17.15
Ultima sincronizare: 2026-08-03
Capitalizare de piață
$6.51M
Schimbare (1 zi)
9.80%
Schimbare (1 an)
289.77%
Țară
US
Tranzacționează Galera Therapeutics, Inc. (GRTX)

Categorie

Istoric al prețului acțiunii pentru Galera Therapeutics, Inc. (GRTX)
Cel mai mare preț de închidere: $17.15 pe 2026-08-01

Cel mai mic preț de închidere: $2.54K pe 2019-11-01
Istoric al prețului acțiunii pentru Galera Therapeutics, Inc. din 2019 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) 98.59%
2025 -26.18%
2024 -76.56%
2023 -91.44%
2022 -45.34%
2021 -73.46%
2020 -7.59%
2019 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$506.54 29.78%
US
$843.80 29.33%
NL
$729.87 6.86%
CH
$1.07K -6.40%
KR
$252.41 11.51%
BE